Sign in
Taking people in United StatesNo phase

Brain stimulation plus talk therapy for insomnia in mild cognitive impairment

Tests magnetic brain stimulation with sleep therapy in people with mild cognitive impairment and insomnia.

Key facts

Who runs it
Beth Israel Deaconess Medical Center
Where
Boston, United StatesSee the site
Trial code
Registry title
Treating Insomnia in Mild Cognitive Impairment
Status
Recruiting
People taking part
30 people, planned
Started
1 May 2025
Expected to end
30 Jun 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Transcranial Magnetic Stimulation (TMS) therapy
  • Cognitive behavioral therapy for insomnia (CBT-I)
Record updated
5 November 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people aged 60 or older with mild cognitive impairment (MCI) or subjective cognitive impairment, who also have insomnia. It tests brain stimulation (TMS) combined with talk therapy for insomnia (CBT-I).

Age
60 Years or older
Sex
All
Disease stage
A clinical diagnosis of MCI or subjective cognitive impairment (a felt, gradual worsening of thinking ability). Insomnia symptoms (trouble falling or staying asleep) causing significant distress or problems in daily life over the past three months.
Earlier treatment
People currently getting psychological treatment for insomnia cannot join.

Main reasons for not taking part

  • Significant cognitive impairment or dementia
  • Reasons you cannot have TMS or MRI
  • Uncontrolled moderate-to-severe obstructive sleep apnea or another untreated sleep disorder (managed sleep apnea stable for ≥3 months is allowed)
  • Parkinson's disease, Huntington's disease, Lewy-Body disease or another neurological condition that affects sleep
  • Current major psychiatric disorder, current opiate/opioid use, or alcohol or drug abuse within the past year

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Aged 60 years or older
  • Speak and read English
  • Clinical diagnosis of MCI or Subjective Cognitive Impairment (SCI)-a perceived gradual worsening in cognitive ability relative to one's younger self, or peer group-reported by either the participant or informant
  • Reported insomnia symptoms (sleep-onset and/or sleep maintenance) that cause significant distress or impairment in social, occupational, or other areas of functioning over the past three months
  • Have access to an Internet-enabled computer or tablet at home, or ability to connect a BIDMC-provided tablet to the internet, with private space to complete cognitive testing
  • Capable of and willing to provide written informed consent

Who cannot take part

  • Alcohol or drug abuse within the past year
  • Evidence of significant cognitive impairment or dementia
  • Uncontrolled moderate-to-severe obstructive sleep apnea or other untreated sleep disorder (e.g., Restless Leg Syndrome, Periodic Limb Movement Disorder, parasomnia). Sleep apnea that is managed (e.g., regular use of a CPAP) and stable for ≥3 months is allowed
  • Diagnosis of Parkinson's disease, Huntington's disease, Lewy-Body disease, or other neurological condition known to impact sleep
  • Current diagnosis of major psychiatric disorder (well-controlled depression or anxiety is permitted)
  • Contraindications for TMS or MRI
  • Current psychological treatment for insomnia
  • Current opiate/opioid use
  • Irregular sleep schedule (bedtime before 8pm/after 2am OR wake time before 4am/after 10am), unless participant states they are willing and able to change if prompted

Where in United States

  • Beth Israel Deaconess Medical CenterBoston, United StatesContact: Alex Clinical Research CoordinatorTaking people

About the trial

What the trial wants to find out

The goal of this study is to test a new way to improve sleep quality in persons living with mild cognitive impairment. The treatment combines a safe and gentle way to stimulate the brain, called transcranial magnetic stimulation, with a psychological treatment, called cognitive behavioral therapy for insomnia.

The 2 groups in the trial

  • One (1) TMS treatment per day plus CBT-IExisting treatment, for comparison

    One (1) daily treatment of intermittent theta-burst stimulation (iTBS) applied to the left dorsolateral prefrontal cortex (L-DLPFC) for 10 days (2 weeks) followed by a 9-week Internet-delivered cognitive behavioral therapy for insomnia (CBT-I) program

    Treatment: Transcranial Magnetic Stimulation (TMS) therapy and Cognitive behavioral therapy for insomnia (CBT-I)

  • Two (2) TMS treatments per day plus CBT-IExisting treatment, for comparison

    Two (2) daily treatments, spaced 1 hour apart, of intermittent theta-burst stimulation (iTBS) applied to the left dorsolateral prefrontal cortex (L-DLPFC) for 10 days (2 weeks) followed by a 9-week Internet-delivered cognitive behavioral therapy for insomnia (CBT-I) program

    Treatment: Transcranial Magnetic Stimulation (TMS) therapy and Cognitive behavioral therapy for insomnia (CBT-I)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Neuromodulation and Cognitive Behavioral Therapy for Insomnia in MCI
Plain-language title
Brain stimulation plus talk therapy for insomnia in mild cognitive impairmentGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Publications
Record updated
5 November 2026